Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLOD2 | O00469 | 3/20 | 0.39 |
| ▸ | PLOD3 | O60568 | 2/20 | 0.38 |
| ▸ | PLOD1 | Q02809 | 2/20 | 0.38 |
| ▸ | FAAH | O00519 | 8/20 | 0.36 |
| ▸ | CES1 | P23141 | 7/20 | 0.34 |
| ▸ | CES2 | O00748 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9720470 | 0.85 | PLOD2 (0.43) | PLOD2PLOD3PLOD1FAAHCES1 | |
| SCHEMBL183178 | 0.78 | PLOD2 (0.46) | PLOD2PLOD3PLOD1FAAHCES1 | |
| SCHEMBL1948056 | 0.76 | TDP1 (0.45) | PLOD2PLOD3PLOD1FAAHCES1 | |
| SCHEMBL1034297 | 0.76 | KMT2A (0.31) | KMT2A | |
| SCHEMBL4976795 | 0.76 | PLOD2 (0.38) | PLOD2PLOD3PLOD1FAAHCES1 | |
| SCHEMBL31303653 | 0.76 | PLOD2 (0.38) | PLOD2PLOD3PLOD1FAAHCES1 | |
| SCHEMBL9283764 | 0.76 | PLOD2 (0.44) | PLOD2PLOD3PLOD1FAAHCES1 | |
| SCHEMBL9326020 | 0.76 | PLOD2 (0.44) | PLOD2PLOD3PLOD1FAAHCES1 | |
| Water SCHEMBL7191917 | 0.76 | PLOD2 (0.44) | PLOD2PLOD3PLOD1FAAHCES1 | |
| Water SCHEMBL7197275 | 0.76 | PLOD2 (0.44) | PLOD2PLOD3PLOD1FAAHCES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11021418-B2 | Method of olefin oligomerization | SK INNOVATION CO., LTD. (KR) | 2021-06-01 | — | — | US | disclosed |
| US-20200262767-A1 | Method of Olefin Oligomerization | SK INNOVATION CO, LTD. (KR) | 2020-08-20 | — | — | US | disclosed |
| US-7378154-B2 | Radiation transparent glass, polycarbonate, polyethylene terephthalate, acrylic, methyl cellulose or polycycloolefin substrate, a fluoropolymer layer containing and a rare earth metal compound, and a low refractive index layer; fluorescence; light amplification; improved efficiency; light emitting diodes | DAIKIN INDUSTRIES, LTD. (JP) | 2008-05-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200262767-A1 | Method of Olefin Oligomerization | OXER1, OSR1, OXSR1 | PLOD2 3092/4885PLOD3 4827/4885PLOD1 3116/4885 |
| US-11021418-B2 | Method of olefin oligomerization | OXER1, OSR1, OXSR1 | PLOD2 3092/4885PLOD3 4827/4885PLOD1 3116/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.